Single Escalating Dose Study Of HSK7653 In Healthy Subjects

Clinical trial NCT05983289 · COMPLETED

Trial details

NCT number: NCT05983289
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

T2DM (Type 2 Diabetes Mellitus)

Start date: 2018-05-08
Primary completion: 2019-07-03
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.